Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Adrenal Gland Disorders01:27

Adrenal Gland Disorders

Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Antihypertensive Drugs: Potassium-Sparing Diuretics01:28

Antihypertensive Drugs: Potassium-Sparing Diuretics

Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
Hormonal Regulation01:33

Hormonal Regulation

The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Antihypertensive Drugs: Action of β1 Blockers01:17

Antihypertensive Drugs: Action of β1 Blockers

β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this, β1-blockers...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Primary aldosteronism.

Nature reviews. Disease primers·2026
Same author

Reaching Blood Pressure Control: A 30-Year Odyssey.

Hypertension (Dallas, Tex. : 1979)·2026
Same author

Pregnancy-Related Complications in Primary Aldosteronism: A European Survey.

Hypertension (Dallas, Tex. : 1979)·2026
Same author

Cardiometabolic Burden in Bilateral Macronodular Adrenal Disease With Primary Aldosteronism.

Hypertension (Dallas, Tex. : 1979)·2026
Same author

Human 3D Cardiac Microtissue Model to Investigate Aldosterone-Induced Fibrosis and Electrical Dysfunction.

Hypertension (Dallas, Tex. : 1979)·2026
Same author

Heart failure associated with renal artery stenosis and Pickering syndrome: the critical role of endovascular revascularization: a case series and meta-analysis.

Clinical hypertension·2026

Related Experiment Video

Updated: Jun 13, 2026

A Novel Method: Super-selective Adrenal Venous Sampling
06:08

A Novel Method: Super-selective Adrenal Venous Sampling

Published on: September 15, 2017

Evaluation of primary aldosteronism.

Paolo Mulatero1, Silvia Monticone, Chiara Bertello

  • 1Division of Internal Medicine and Hypertension, Department of Medicine and Experimental Oncology, University of Torino, Torino, Italy. paolo.mulatero@libero.it

Current Opinion in Endocrinology, Diabetes, and Obesity
|April 15, 2010
PubMed
Summary

Primary aldosteronism, a common endocrine hypertension cause, is increasingly prevalent in severe hypertension cases. Early detection and targeted treatment are crucial for reducing cardiovascular risks and target organ damage.

More Related Videos

Primary Culture of Rat Adrenocortical Cells and Assays of Steroidogenic Functions
04:33

Primary Culture of Rat Adrenocortical Cells and Assays of Steroidogenic Functions

Published on: March 12, 2019

Related Experiment Videos

Last Updated: Jun 13, 2026

A Novel Method: Super-selective Adrenal Venous Sampling
06:08

A Novel Method: Super-selective Adrenal Venous Sampling

Published on: September 15, 2017

Primary Culture of Rat Adrenocortical Cells and Assays of Steroidogenic Functions
04:33

Primary Culture of Rat Adrenocortical Cells and Assays of Steroidogenic Functions

Published on: March 12, 2019

Area of Science:

  • Endocrinology
  • Cardiovascular Medicine
  • Hypertension Management

Background:

  • Primary aldosteronism is the most frequent cause of endocrine hypertension.
  • Its prevalence rises with hypertension severity, affecting up to 20% of resistant hypertensive patients.
  • Primary aldosteronism increases cardiovascular events and target organ damage risk compared to essential hypertension.

Purpose of the Study:

  • To summarize current knowledge on the diagnosis and treatment of primary aldosteronism.
  • To highlight the importance of early detection for targeted therapy and risk reduction.

Main Methods:

  • Review of current diagnostic strategies for primary aldosteronism.
  • Emphasis on the three-step diagnostic process: screening, confirmation, and subtype diagnosis.
  • Discussion of updated guidelines and ongoing diagnostic debates.

Main Results:

  • Prevalence of primary aldosteronism ranges from 2% in grade 1 hypertension to 20% in resistant hypertension.
  • Early detection offers opportunities for targeted treatment.
  • Patients with primary aldosteronism face higher risks of cardiovascular events and target organ damage.

Conclusions:

  • Accurate identification of primary aldosteronism is essential.
  • New guidelines play a central role in diagnostic strategies.
  • Certain diagnostic aspects remain under discussion and require further clarification.